The S&P 500's cyclically adjusted valuation metric has surged to a level seen only twice in the past century—each time preceding a historic crash. As 2026 approaches, investors are weighing whether AI-driven growth can defy historical precedent.
New Jersey's retail sector faces sustained pressure as bankruptcy filings hit a 15-year high. Rising interest rates, shifting consumer habits, and policy uncertainty converge, forcing iconic chains and local staples alike to restructure or shutter.
China's search and AI pioneer Baidu announces a landmark $5 billion share repurchase plan and its inaugural dividend, aligning with tech peers to return capital as growth from its generative AI bets cools.
Severe winter storms across key regions contributed to a slower-than-expected January for US light vehicle sales, with adjusted figures showing a 3.3% year-over-year decline, though analysts see potential for a rebound.
Ethereum's price decline accelerates following a confirmed technical breakdown and notable selling by founder Vitalik Buterin. On-chain data reveals a synchronized pullback by large holders and long-term investors, raising the stakes for a critical support test near $1,800.
A surreal exchange on Capitol Hill saw lawmakers question the possibility of a federal Bitcoin bailout, with Treasury officials firmly rejecting the idea and underscoring the asset's detachment from traditional government safeguards.
The heavily restricted reopening of Gaza's Rafah crossing has allowed a trickle of medical evacuations and the return of some displaced Palestinians, who describe arduous and degrading Israeli security procedures. The process falls far short of needs as attacks continue despite a nominal ceasefire.
A bipartisan bill in Congress aims to restore $160 million in federal funding to Brand USA, the nation's tourism promoter, seeking to capitalize on major upcoming events like the 2026 World Cup and 2028 Olympics to boost inbound travel and hotel demand.
Sotera Health's stock presents a valuation conundrum, with discounted cash flow analysis suggesting a 37% upside while its sky-high P/E ratio signals overvaluation. As investors reassess biotech and pharmaceutical services firms, the debate intensifies around SHC's true worth.
Shares of ADMA Biologics (NASDAQ: ADMA) are trading near $16.49, presenting a stark contrast to valuation models. A detailed analysis using Discounted Cash Flow and a proprietary Fair P/E ratio suggests the biopharma stock may be deeply undervalued, despite recent mixed trading momentum.
Kyocera's shares have surged over 27% in three months, pushing its valuation to a premium. Analysts are divided on whether the momentum reflects a fundamental re-rating or a speculative bubble, as growth forecasts remain modest.
Moelis & Co's stock has faced significant headwinds over the past year, declining over 7%. While its long-term performance remains robust, recent weakness prompts a closer look at its valuation through multiple lenses—from excess returns to P/E ratios—to determine if the market has overcorrected.
As Russia intensifies winter attacks on Ukraine's energy infrastructure, negotiators from both sides, with U.S. envoys present, continue high-stakes talks seeking a path to end the nearly four-year war, despite a reported surge in civilian casualties.
Meta expands its clean energy portfolio through a new power purchase agreement with Zelestra for the Skull Creek Solar Plant in Texas, part of a broader 1.2GWdc partnership aiming for full operation by 2028.
Siemens Healthineers reported a resilient start to fiscal 2026, with strong performance in its imaging and precision therapy divisions offsetting a significant downturn in its diagnostics business in China, prompting a strategic reassessment of its operations in the key Asian market.
The Swiss pharma giant reported robust 2025 results, hitting a key profitability goal early. While facing near-term pressure from U.S. generic competition, CEO Vas Narasimhan outlined a strategy anchored by a portfolio of growth brands and a promising late-stage pipeline.
In a major policy reversal, the U.S. Commodity Futures Trading Commission has formally withdrawn a contentious 2024 proposal that sought to outlaw event contracts tied to politics, sports, and conflict. Chairman Michael S. Selig dismissed the plan as a politically motivated overreach, signaling the agency's intent to regulate—not stifle—the fast-growing prediction market sector.
An early projection suggests a smaller cost-of-living adjustment for 2027, renewing concerns about benefits keeping pace with retirees' actual expenses.
Automotive supplier Lear Corporation reported robust 2025 financial results, highlighted by record new business awards in seating and E-Systems, significant operational savings, and a disciplined capital return strategy. While navigating a mixed global auto market, the company outlined a confident outlook for 2026, underpinned by its thermal comfort technology and digital transformation initiatives.
A wave of analyst upgrades, including a key move to 'Outperform,' is refocusing investor attention on Airbnb's stock. The renewed confidence arrives as the company navigates a mixed performance record, prompting a fresh look at whether its current share price adequately reflects future growth prospects.
